Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2003
12/31/2003WO2004001002A2 Novel anticholesterol compositions and method for using same
12/31/2003WO2004000979A1 Process for recovery of plant sterols from by-product of vegetable oil refining
12/31/2003WO2004000869A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders
12/31/2003WO2004000854A1 Sulfur-containing phospholipid derivatives
12/31/2003WO2004000849A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
12/31/2003WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003WO2004000842A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
12/31/2003WO2004000841A1 Hetero-bicyclic compounds
12/31/2003WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors
12/31/2003WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
12/31/2003WO2004000831A1 Indole derivatives useful as histamine h3 antagonists
12/31/2003WO2004000830A1 Novel compounds, their use and preparation
12/31/2003WO2004000829A1 Novel process
12/31/2003WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/31/2003WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003WO2004000813A1 Phenoxypyridine derivative or salt thereof
12/31/2003WO2004000807A1 Cannabinoid receptor agonists
12/31/2003WO2004000805A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
12/31/2003WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003WO2004000803A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
12/31/2003WO2004000791A1 Benzene derivative
12/31/2003WO2004000790A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003WO2004000785A2 Phenyloxyalkanonic acid derivatives as hppar activators
12/31/2003WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003WO2004000762A2 Propionic acid derivatives and their use as hppars activators
12/31/2003WO2004000354A2 Method of treating the syndrome of lipodystrophy
12/31/2003WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
12/31/2003WO2004000327A1 Therapeutic agent for type 2 diabetes
12/31/2003WO2004000326A1 Combination therapy wherein a serotonin reuptake inhibitor is used
12/31/2003WO2004000315A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003WO2004000307A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor
12/31/2003WO2004000299A1 Body fat degradation promoters and foods and drinks
12/31/2003WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003WO2004000294A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003WO2004000292A1 Composition comprising stabilised choline ascorbate
12/31/2003WO2004000279A1 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
12/31/2003WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation
12/31/2003WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
12/31/2003WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
12/31/2003WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/31/2003WO2003074513A3 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
12/31/2003WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/31/2003WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
12/31/2003WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003WO2003060475A3 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003WO2003055916A3 Adiponectin fragments and conjugates
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003033734A3 Diagnostic tests for the diagnosis of copper storage disease
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2003006492A3 Biologically active peptides
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002048110A3 Composition for regulating animal growth, method of manufacture and use thereof
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002043578A3 Determination of risk and treatment of complications of prematurity
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2001006984A3 Small molecules useful in the treatment of inflammatory disease
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1464791A Compositions for protein delivery via the pulmonary route
12/31/2003CN1463750A Emulsifying agent for preparing milky white cod liver oil
12/31/2003CN1463745A Replenisher containing complete nutrescin
12/31/2003CN1463737A A fatty acid synthetase depressant, method for preparing same and use thereof
12/31/2003CN1463734A A prepared Chinese medicine for treating diabetes mellitus and method for preparing same
12/31/2003CN1463725A A pharmaceutical compound for treating diabetes and insuline resistance syndrome
12/31/2003CN1463710A Capsule for treating diabetes and nephrodystrophy
12/31/2003CN1463709A Yuzu capsule
12/31/2003CN1463707A Tortoise and turtle calcium extract
12/31/2003CN1132615C Health-care product with function of regulating blood sugar and its preparation method
12/31/2003CN1132610C Chinese medicine for treating diabetes and neurovascular lesion of both feet and its preparing process
12/31/2003CN1132607C Yunnan pine nut extract and preparation process and use thereof
12/31/2003CN1132594C Extracting deoxy enamine mycin derivatives by folium mori and medical use
12/31/2003CN1132591C Chewing tablets of pilose antler, deerhorn and deer bone and preparing process thereof
12/31/2003CN1132578C Use of dipeptidyl peptidase IV inhibitors for lowering the blood glucose level mammals
12/31/2003CA2501963A1 Process for recovery of plant sterols from by-product of vegetable oil refining
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003CA2490526A1 Hetero-bicyclic compounds
12/31/2003CA2490452A1 .beta.-glucan-containing fat and oil composition and novel microorganism capable of producing .beta.-glucan
12/31/2003CA2490341A1 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2490112A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
12/31/2003CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003CA2490108A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
12/31/2003CA2489702A1 Novel anticholesterol compositions and method for using same
12/31/2003CA2489359A1 Propionic acid derivatives and their use as hppars activators
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003CA2487909A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/31/2003CA2485537A1 Novel compounds, their use and preparation
12/31/2003CA2485220A1 Methods for identifying glucose uptake modulators
12/30/2003US6670481 Oxiranecarboxylic acids for the treatment of diabetes
1 ... 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 ... 1298